CARLOS
OCHOA SANGRADOR
Researcher in the period 2019-2022
![Foto de CARLOS](/img/uploaded/4864c788233f23b801fb175de837cdb3.jpg)
![Foto de Technion – Israel Institute of Technology](/img/noimage_org.png)
Technion – Israel Institute of Technology
Haifa, IsraelPublications in collaboration with researchers from Technion – Israel Institute of Technology (1)
2022
-
Efficacy and safety of empagliflozin in glycogen storage disease type Ib: Data from an international questionnaire
Genetics in Medicine, Vol. 24, Núm. 8, pp. 1781-1788